P3 Health Partners INC 8-K filings

P3 Health Partners has received a notice from Nasdaq that its stock price has fallen below the minimum $1.00 threshold for continued listing, triggering a potential delisting process.

P3 Health Partners has announced the appointment of Aric Coffman as its new Chief Executive Officer and President, succeeding Sherif Abdou, who will transition to Vice Chairperson of the Board.

P3 Health Partners announced a 29% year-over-year revenue increase for the first quarter of 2024, while also welcoming a new CEO and reaffirming their financial guidance for the year.

P3 Health Partners secured a $25 million financing agreement and reported a 21% year-over-year revenue increase for 2023, exceeding their initial guidance.

P3 Health Partners Inc. has updated its bylaws to incorporate universal proxy rules and streamline procedures for stockholder nominations and proposals.